Vaccination

FDA panel endorses booster shot for J&J COVID-19 vaccine

U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands.

Vaccination

FDA panel takes up tough questions on J&J COVID-19 boosters

U.S. health advisers on Friday tackled who should get boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when—and whether using a competing brand for the second dose might provide better protection.

Vaccination

CDC expert panel to weigh in on vaccine boosters

(HealthDay)—An advisory panel to the U.S. Centers for Disease Control and Prevention will meet on Wednesday to discuss which Americans, if any, should get Pfizer booster shots to rev up their immunity to COVID-19.

Vaccination

Top doctors say not so fast to Biden's boosters-for-all plan

Just one month ago, President Joe Biden and his health advisers announced big plans to soon deliver a booster shot of the coronavirus vaccine to all Americans. But after campaigning for the White House on a pledge to "follow ...

Vaccination

US panel backs COVID-19 boosters only for seniors, high-risk

Dealing the White House a stinging setback, a government advisory panel overwhelmingly rejected a plan Friday to give Pfizer COVID-19 booster shots across the board, and instead endorsed the extra vaccine dose only for those ...

page 5 from 11